Key Questions about COVID-19 Vaccine Passports and the U.S.
This issue brief provides an overview of COVID-19 vaccine passports, including what they are, where they are being used, and potential implementation issues.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This issue brief provides an overview of COVID-19 vaccine passports, including what they are, where they are being used, and potential implementation issues.
Booster update remains modest; half of those already boosted are waiting for updated CDC guidelines to get another dose Nearly four in ten (38%) people say their households were affected by this winter's triple threat of viruses, with someone getting sick with the flu, COVID-19, or respiratory syncytial virus (RSV), and nearly half (46%) say the news of these three viruses spreading has made them more likely to wear masks or take other precautions to…
This data note arrays and groups PEPFAR countries by their level of “sustainability readiness” in order to help inform discussions about PEPFAR’s work on sustainability,
This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.
This policy watch examines global access to COVID-19 vaccines by country income level, assessing country income levels' shares of purchased doses and potential vaccination coverage, while also looking closely at the potential impact of COVAX in addressing vaccine access disparity between high-income and low- and middle-income countries.
As part of the Biden administration’s plans to facilitate more equitable access to vaccinations, the administration has formed a partnership with community health centers, known for providing health care to some of the hardest-to-reach populations. This Policy Watch post examines the initial group of health centers to participate early in the Health Center Vaccination Program and the patient populations they serve.
This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.
More than half (54%) of rural adults say they have already gotten at least one dose of a COVID-19 vaccine or will do so as soon as possible, as rural residents report less issues with both supply and access than those living in urban and suburban areas, according to a new KFF COVID-19 Vaccine Monitor report focused on rural America. A somewhat larger share of rural residents (39%) than those living in urban (31%) or suburban…
With supply having increased significantly and eligibility fully open to adults in all states as of April 19, this analysis estimates that COVID-19 vaccine supply will exceed demand across the U.S. over the next 2 to 4 weeks.
This issue brief presents current state-level data about COVID-19 cases and deaths in settings that primarily serve nonelderly people with disabilities and summarizes available research on this population’s elevated risk of severe illness and death; explains how nonelderly people with disabilities and their LTSS providers are reflected in state vaccine prioritization plans; and discusses key issues related to vaccine access for these populations.
© 2026 KFF